CTRI/2017/08/009505
Completed
未知
Examination of therapeutic efficacy and potential mechanisms of yoga treatment in schizophrenia - Yoga-Schiz-multicentric-study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of science and technology
- Enrollment
- 96
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Schizophrenia Subject 1\)ICD 10diagnosisof schizophrenia 2\) capacity to provide informed consent 3\)no other current comorbid axis I diagnosis (except nicotine abuse/dependence) and no general impaired intellectual functioning
- •Healthy volunteers:â??1\) Males and females between 18 and 45 years
- •2\)Capacity to provide informed consent
- •3\) absence of past or present psychiatric illnesses including substance abuse 4\) no general impaired intellectual functioning
Exclusion Criteria
- •Exclusion criteria for both Patients and controls
- •1\)Other current comorbid axis I diagnosis (except nicotine abuse/dependence) and general impaired intellectual functioning
- •2\) History of alcohol or substance abuse or dependence in the last 12 months (with the exception of nicotine)
- •3\)Past history of head injury resulting in loss of consciousness or neurosurgery
- •4\)Concomitant severe medical conditions
- •5\)Change in dose of antipsychotic medication or Electroconvulsive therapy in the past 6weeks 6\)Pregnant or lactating
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Verification of feasibility and therapeutic effects by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patientsstrokeJPRN-UMIN000050318Fukunagakinen Clinic2
Not yet recruiting
Phase 2
Drakshathi chooram for Pandu noi anaemia A pilot studyHealth Condition 1: D539- Nutritional anemia, unspecifiedCTRI/2022/02/040567ational institute ofsiddha
Not yet recruiting
Phase 3
therapeutic effectiveness of Siddha formulation Thanneervittan Nei in the management of Moothirakiricharam (Urinary Tract Infection) â?? A Pilot studyHealth Condition 1: N390- Urinary tract infection, site notspecifiedCTRI/2022/03/040777ational institute of siddha
Recruiting
Phase 2
Therapeutic effect of dalfampridine on patients with Devic syndromeDevic.Neuromyelitis optica [Devic]G36.0IRCT20210917052506N1Esfahan University of Medical Sciences70
Completed
Phase 4
Evaluation of the therapeutic efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated falciparum malaria in areas of artemisinin-resistant falciparum malaria in Viet NamACTRN12618001274268Ministry of Health, Viet Nam153